| Date Filed | Type | Description |
| 03/09/2023 |
SC 13G
| KOTLER KEVIN reports a 5.1% stake in Avadel Pharmaceuticals plc |
| 03/02/2023 |
3
| KOTLER KEVIN (Director) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/ |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/20/2022 |
SC 13G
| KOTLER KEVIN reports a 6.3% stake in Relmada Therapeutics, Inc. |
| 06/06/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/22/2022 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 7,588,395 shares
@ $0
Disposed/sold 22,685 restricted stock units
@ $0
Disposed/sold 7,500 options to buy
@ $2.93, valued at
$22k
Disposed/sold 85,760 options to buy
@ $3.66, valued at
$313.9k
|
|
| 02/15/2022 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Converted 2,422,222 shares
@ $1.8, valued at
$4.4M
Converted 436 convertible preferred
@ $1.8, valued at
$784.8 |
|
| 01/31/2022 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 85,760 options to buy
@ $0
Granted 15,369 restricted stock units
@ $0
Exercised 7,684 restricted stock units
@ $0 |
|
| 11/22/2021 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Bought 100,000 shares
@ $3.06, valued at
$306k
|
|
| 11/15/2021 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Bought 100,000 shares
@ $3.2, valued at
$320k
|
|
| 11/09/2021 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Bought 257,800 shares
@ $3.47, valued at
$894.6k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2020 |
4
| Broadfin Healthcare Master Fund Ltd (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 10,623 shares
@ $2.93, valued at
$31.1k
Converted 10,623 options
@ $2.93, valued at
$31.1k
|
|
| 01/15/2020 |
3
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 3 on NOVELION THERAPEUTICS INC. |
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2019 |
4
| Broadfin Healthcare Master Fund Ltd (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Sold 2,206,243 shares
@ $6.037, valued at
$13.3M
Sold 293,757 shares
@ $5.9034, valued at
$1.7M
Sold 1,500,000 shares
@ $5.9, valued at
$8.9M
Converted 4,000,000 shares
@ $1.8, valued at
$7.2M
Converted 720 convertible preferred
@ $1.8, valued at
$1.3k
|
|
| 08/15/2019 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 18,123 shares
@ $0
Exercised 18,123 restricted stock units
@ $0 |
|
| 08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2019 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 7,258,135 shares
@ $0 |
|
| 05/14/2019 |
4
| Broadfin Healthcare Master Fund Ltd (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Sold 1,800,000 shares
@ $5, valued at
$9M
Converted 324 convertible preferred
@ $1.8, valued at
$583.2 |
|
| 04/15/2019 |
4
| Broadfin Healthcare Master Fund Ltd (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Sold 2,000,000 shares
@ $5, valued at
$10M
Converted 360 convertible preferred
@ $1.8, valued at
$648 |
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2019 |
3
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 3 on ARATANA THERAPEUTICS, INC. |
| 12/27/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Sold 400 shares
@ $0.98, valued at
$392
Sold 1,200 shares
@ $0.9325, valued at
$1.1k
Sold 83,245 shares
@ $0.9784, valued at
$81.4k
Sold 12,450 shares
@ $0.9078, valued at
$11.3k
Sold 109,900 shares
@ $0.872, valued at
$95.8k
Sold 12,219 shares
@ $0.9091, valued at
$11.1k
Sold 28,745 shares
@ $0.9058, valued at
$26k
Sold 30,726 shares
@ $0.907, valued at
$27.9k
Sold 14,800 shares
@ $0.8803, valued at
$13k
Sold 56,316 shares
@ $0.8548, valued at
$48.1k
Sold 100,000 shares
@ $0.8514, valued at
$85.1k
|
|
| 12/13/2018 |
3
| KOTLER KEVIN (Director) has filed a Form 3 on AVADEL PHARMACEUTICALS PLC |
| 11/28/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Corium International, Inc.|
Txns:
| Unknown transaction of 4,474,995 shares
@ $0 |
|
| 10/15/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/16/2018 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 3,124 restricted stock units
@ $0 |
|
| 08/13/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Gifted 10,000 options to buy
@ $0 |
|
| 08/07/2018 |
3/A
| KOTLER KEVIN (Director) has filed a Form 3/A on BIODELIVERY SCIENCES INTERNATIONAL INC |
| 08/03/2018 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 96,247 restricted stock units
@ $0
Granted 48,123 options to buy
@ $2.93, valued at
$141k
|
|
| 05/24/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Sold 29,300 shares
@ $5.84, valued at
$171.1k
Sold 38,000 shares
@ $5.99, valued at
$227.6k
Sold 45,700 shares
@ $6, valued at
$274.2k
Sold 50,000 shares
@ $5.65, valued at
$282.5k
Sold 25,000 shares
@ $5.51, valued at
$137.8k
|
|
|